# University of Alabama at Birmingham (UAB) Pediatric CBD Program

> **NCT02695537** · PHASE1 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 89 (actual)

## Conditions studied

- Epilepsy
- Seizures

## Interventions

- **DRUG:** Epidiolex

## Key facts

- **NCT ID:** NCT02695537
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2019-02-27
- **Final completion:** 2019-02-27
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2020-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02695537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02695537, "University of Alabama at Birmingham (UAB) Pediatric CBD Program". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02695537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*